Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

CASI Pharmaceuticals Has Entered Into An Exclusive Distribution Agreement With China National Medicines Corporation Ltd. For The Distribution Of Pralatrexate For Injection In China, Excluding Hong Kong SAR, Taiwan, And Macau, For A Period Of One Year

Author: Benzinga Newsdesk | December 08, 2023 05:28pm

- SEC Filing

Posted In: CASI